Phillips Medisize

Two scientists walking in a manufacturing plant in sterile coveralls and face masks demonstrating CDMO quality and regulatory services using laptop computer.

From Dis­cov­ery to De­liv­ery, We Build Trust

As a contract development and manufacturing organization (CDMO), the world’s leading pharmaceutical, medtech and in vitro diagnostic companies trust us to help them design and manufacture their products. Across the US, Europe and Asia, we engage with each customer we are privileged to serve in a tailored, highly personalized way by listening, asking questions and embracing your engineering challenges. That’s because we believe the C in CDMO also represents Care – the Care we take in engineering your products and the Care these devices ultimately deliver to patients.

INDUSTRIES WE SERVE

PHAR­MA

MED­TECH

IN VITRO
DI­AG­NOS­TICS

NON-MED­ICAL

Molex, a parent to Phillips Medisize, Closes Acquisition of Vectura Group Ltd. Learn more.

News and Events

Webpage
A female scientist working in a formulation and development lab at Vectura working on inhalation capabilities
Adding market-leading inhalation capabilities to our suite of drug delivery device design and production capabilities
Combining the strengths of Phillips Medisize and Vectura enhances our ability to deliver a broader portfolio of innovative inhalation solutions to our pharmaceutical partners and to fulfill our shared vision of helping patients live healthier lives. Learn More.
News
Phillips Medisize employee working in the pharmaceutical technology service lab, while we can see another employee walk past outside the window. Through the window, another corridor shows another employee in a neighbouring room.
Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited
Vectura is a leader in inhalation drug device design and formulation, based in Chippenham, United Kingdom. Read more.
News
Four men receiving reddot award for product design 2023
SKYTROFA® Auto-Injector Award
In collaboration with their customer, Ascendis Pharma, Phillips-Medisize was recently recognized with a third prestigious industry award for the SKYTROFA® Auto-Injector. The award recognizes the drug delivery device's exceptional design and positive impact. The first-of-its-kind product that enables convenient and efficient preparation and delivery of SKYTROFA—a vital growth hormone treatment for children.  Read more.